Sort
48,018 grants matching “immunotherapy”
Nanoscale Coordination Polymers of Cyclic-di-nucleotides and Peptide Antigens for Effective Therapy of Metastatic Colorectal Cancer
$446,134Ralph R Weichselbaum · University Of Chicago · R01 · FY2023 · CA
The Antigen Repertoire of CD4 T cells from Pancreatic Islets
$446,132Maki Nakayama · University Of Colorado Denver · R01 · FY2024 · DK
The role of transcription elongation defects in immunotherapy resistance in cancers
$446,129Fukun Guo · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · CA
The role of transcription elongation defects in immunotherapy resistance in cancers
$446,129Fukun Guo · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · CA
The role of transcription elongation defects in immunotherapy resistance in cancers
$446,129Fukun Guo · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · CA
Quantitative single-cell biomarkers of T-cells to optimize tumor immunotherapy
$446,107Navin Varadarajan · University Of Houston · R01 · FY2013 · CA
Translational Research in Surgical Oncology
$446,107Herbert Kim Lyerly · Duke University · T32 · FY2018 · CA
Immunoregulatory networks and HIV pathogenesis
$446,075Daniel E Kaufmann · Massachusetts General Hospital · R01 · FY2007 · HL
Immunoregulatory networks and HIV pathogenesis
$446,075Daniel E Kaufmann · Massachusetts General Hospital · R01 · FY2008 · HL
KRAS inhibitors prime cancer cells for macrophage-mediated destruction
$446,063Kipp A Weiskopf · Whitehead Institute For Biomedical Res · R01 · FY2025 · CA
Targeting ER+ Breast Cancer Through Induced Viral Mimicry
$446,063Charles H Spruck · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · CA
Targeting the FBXO44/SUV39H1 Pathway in Cancer
$446,063Charles H Spruck · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · CA
KRAS inhibitors prime cancer cells for macrophage-mediated destruction
$446,063Kipp A Weiskopf · Whitehead Institute For Biomedical Res · R01 · FY2023 · CA
Translational regulation of CD8 T cell immunity
$446,059Koichi Araki · Emory University · R01 · FY2018 · AI
Platelet Factor 8 As A Novel Therapy for Hemophilia A
$445,958Mortimer Poncz · Children'S Hosp Of Philadelphia · P01 · FY2014 · HL
Targeting autophagy to enhance immune checkpoint inhibition
$445,954Ravi K Amaravadi · Wistar Institute · P50 · FY2022 · CA
Project 1: Nanotherapies for Vemurafenib Resistant Melanoma
$445,923Leaf Huang · Univ Of North Carolina Chapel Hill · U54 · FY2019 · CA
B. anthracis:passive immunization with anticapsular mAb
$445,894University Of Nevada Reno · R01 · FY2004 · AI
Targeting tumor architecture as a novel therapeutic strategy for pancreatic cancer
$445,861Matteo Ligorio · Ut Southwestern Medical Center · R37 · FY2024 · CA
Genetic dissection of Id3-mediated pathways in gamma/delta lineage development
$445,860Yuan Zhuang · Research Inst Of Fox Chase Can Ctr · P01 · FY2015 · AI
Critical Role for Microvasculature in Airway Transplantation
$445,841Mark Robert Nicolls · Palo Alto Veterans Instit For Research · R01 · FY2021 · HL
Protein O-GlcNAcylation in Regulatory T Cell Function
$445,829Hai-Bin Ruan · University Of Minnesota · R01 · FY2019 · AI
Protein O-GlcNAcylation in Regulatory T Cell Function
$445,829Hai-Bin Ruan · University Of Minnesota · R01 · FY2020 · AI
Project 2: Understanding the Cellular Origins of Melanoma
$445,780Anand K Ganesan · University Of California-Irvine · U54 · FY2019 · CA
Role of necroptosis in colorectal cancer therapy
$445,723Lin Zhang · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA